āĻšā§āĻŽA2RR34 âĸ BVMF
add
Arrowhead Pharmaceuticals Inc
ā§Ž.ā§Ļā§ŽÂ R$
ā§Šā§Ļ āĻāĻĒā§āĻ°āĻŋ, ā§§:ā§¨ā§§:ā§Ļā§Ģ PM GMT -ā§Š · BRL · BVMF · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
BR-āĻ āĻ¤āĻžāĻ˛āĻŋāĻāĻžāĻā§āĻā§āĻ¤ āĻ¸āĻŋāĻāĻŋāĻāĻ°āĻŋāĻāĻŋāĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ āĻ¯ā§āĻā§āĻ¤āĻ°āĻžāĻˇā§āĻā§āĻ°-āĻ āĻšā§āĻĄāĻā§ā§āĻžāĻ°ā§āĻāĻžāĻ°
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§Ž.ā§Ļā§ŽÂ R$
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§.ā§¨ā§Ē R$ - ā§§ā§Ž.ā§Ēā§ŽÂ R$
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§§ā§Žā§.ā§Ģā§ŽÂ āĻā§ USD
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§Šā§¯ā§Ģ.ā§Ļā§Ļ
āĻāĻŦāĻ°ā§ āĻ°ā§ā§āĻā§
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (USD) | āĻĄāĻŋāĻ¸ā§ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§¨ā§Ģ.ā§Ļā§Ļ āĻ˛āĻž | -ā§¨ā§¯.ā§Ŧā§Ļ% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§§ā§Ŧ.ā§Šā§¯Â āĻā§ | ā§§ā§.ā§Ļā§Ļ% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§§ā§.ā§Šā§§Â āĻā§ | -ā§Šā§Ļ.ā§¨ā§% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | -ā§Ŧ.ā§¯ā§¨Â āĻšāĻž | -ā§Žā§Ģ.ā§Ļā§Ē% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | -ā§§.ā§Šā§¯ | -ā§§ā§¨.ā§§ā§Ļ% |
EBITDA | -ā§§ā§Ģ.ā§Ŧā§¨Â āĻā§ | -ā§§ā§Ž.ā§Ļā§Ŧ% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | -ā§Ļ.ā§Ļā§Ŧ% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (USD) | āĻĄāĻŋāĻ¸ā§ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§Ģā§Ģ.ā§Ļā§ŽÂ āĻā§ | ā§§ā§Ģā§Ž.ā§§ā§Ģ% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§§ā§Ļā§§.ā§Šā§Â āĻā§ | ā§Ŧā§§.ā§Žā§Ŧ% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§¯ā§Ģ.ā§ā§Ŧ āĻā§ | ā§§ā§§ā§§.ā§Ģā§¯% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Ģ.ā§Ŧā§§Â āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§§ā§¨.ā§Ŧā§§Â āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§§ā§¯.ā§¨ā§Ē | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | -ā§Šā§.ā§Ēā§Ž% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | -ā§Ēā§Ļ.ā§¯ā§Ē% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (USD) | āĻĄāĻŋāĻ¸ā§ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§§ā§.ā§Šā§§Â āĻā§ | -ā§Šā§Ļ.ā§¨ā§% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | -ā§§ā§Ē.ā§Ŧā§ŠÂ āĻā§ | -ā§¨ā§Ē.ā§§ā§Š% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | ā§.ā§Ŧā§¯Â āĻā§ | ā§§ā§Ž.ā§Ŧā§¨% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | ā§¨.ā§Ļā§Ŧ āĻā§ | ā§,ā§Ŧā§¨ā§Ž.ā§Ļā§¯% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | -ā§Ē.ā§Žā§ŽÂ āĻā§ | ā§.ā§Šā§% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | -ā§§ā§§.ā§Ēā§Ē āĻā§ | ā§Šā§Š.ā§Šā§Ž% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowheadâs products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§§ āĻāĻžāĻ¨ā§, ā§¨ā§Ļā§Ļā§Ē
āĻ¸āĻĻāĻ° āĻĻāĻĒā§āĻ¤āĻ°
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§Ŧā§Ļā§¯
